Susquehanna Downgrades Warner Chilcott (WCRX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Leerink Swann Downgrades Warner Chilcott (WCRX) to Market Perform
May 22, 2013 7:03 AM EDTLeerink Swann downgraded Warner Chilcott (NASDAQ: WCRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Warner Chilcott click here. For more ratings news on Warner Chilcott click here.
Shares of Warner Chilcott closed at $20.61 yesterday, with a 52 week range of $10.85-$20.64.... More
Warner Chilcott (WCRX) / Actavis (ACT) Deal Features $160M Termination Fee
May 20, 2013 4:56 PM EDTThis Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. According to filings, the deal has a $160 million termination fee.
From Filing: "The Transaction Agreement contains... More
UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 20, 2013 11:01 AM EDT(Updated - May 20, 2013 11:43 AM EDT)
Lazard Capital downgraded Warner Chilcott (NASDAQ: WCRX) from Buy to Neutral. This morning it was learned that Actavis (NYSE: ACT) entered into a definitive agreement under which Actavis will acquire Warner Chilcott in a... More
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
May 20, 2013 7:16 AM EDTValeant Pharmaceuticals (NYSE: VRX) and Mylan (NYSE: MYL), both potential suitors for Actavis, Inc. (NYSE: ACT) are on watch after Actavis announced its own $8.5 billion deal for Warner Chilcott plc (NASDAQ: WCRX) today.... More
Actavis (ACT) to Acquire Warner Chilcott (WCRX) in $8.5B Deal
May 20, 2013 7:08 AM EDTActavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. If successfully completed, the transaction will create a leading global specialty pharmaceutical company with approximately $11 billion in combined annual revenue, and the third-largest U.S. specialty pharmaceutical company with approximately $3 billion in annual revenues focused on core therapeutic categories of Women's Health, Gastroenterology, Urology and Dermatology. The proposed transaction has been unanimously... More
